UK health authorities announced the approval of the first oral antiviral medicine for COVID-19 treatment on November 4, becoming the first country in the world to authorize the drug. The pill, Molnupiravir, is produced by Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics. “As an oral therapeutic, Molnupiravir offers an important addition to the vaccines and medicines deployed so far to counter the COVID-19 pandemic,” said Dr Dean Y Li, executive vice president and president at Merck Research Laboratories. In a statement, Merck said the drug was for “the treatment of mild-to-moderate COVID-19 in adults with a positive SARS-CoV-2 diagnostic test and who have at least one risk factor for developing severe illness.” Footage released by Merck & Co shows researchers working on the drug and manufacturers producing it for distribution. Credit: Merck & Co. via Storyful
from Breaking National News and Australian News | Daily Telegraph https://ift.tt/3wisWI8
Post Top Ad
Responsive Ads Here
Thursday, November 4, 2021
Home
Breaking National News and Australian News | Daily Telegraph
Merck’s COVID Pill Approved by UK Health Authority
Merck’s COVID Pill Approved by UK Health Authority
Tags
# Breaking National News and Australian News | Daily Telegraph
Share This
About Unknown
Breaking National News and Australian News | Daily Telegraph
Subscribe to:
Post Comments (Atom)
Post Bottom Ad
Responsive Ads Here
Author Details
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.
No comments:
Post a Comment